ArticleDiabetologia2026

Safety of glucagon-like peptide-1 receptor agonists and other new-generation glucose-lowering agents for the management of type 2 diabetes in pregnancy: a French nationwide population-based study.

Mathis Collier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.